Tailoring Immunotherapy in Gastrointestinal Cancer: The Role of Circulating Factors

  • 4,739

    Total downloads

  • 15k

    Total views and downloads

About this Research Topic

Submission closed

Background

Gastrointestinal tumors are a heterogeneous disease setting, covering colorectal, gastric, esophageal, pancreatic and liver cancers, and are still the most common causes of cancer-related death worldwide. Despite the improvement in chemoradiotherapy, surgery and targeted therapies alike, the overall 5-years survival rate of gastrointestinal cancer patients remains less than 15%. The difficulties in early diagnosis, the rapid progression of the disease and the resistance to therapies render the necessity to develop new personalized therapies a high priority. In recent years, immunotherapy-based agents undoubtedly opened new therapeutic opportunities in fighting these cancers. Nevertheless, the assessment of microsatellite instability status and expression of immune checkpoint molecules have not been established as sole biomarkers for the clinical practice of immunotherapy.

The goal of this Research Topic is to describe new potential immunological parameters which are mandatory for the development of a new age of precision oncology to treat gastrointestinal cancer patients with immunotherapies. These new biomarkers arise from two critical aspects of gastrointestinal cancers:
i) The heterogeneity of gastrointestinal tumors, if they affect either different tissues, or the same tissues.
ii) The complexity of the immune landscape of the tumor microenvironment. For example, some subclasses of colorectal cancers represent the so-called "hot tumors", while other cancers such as pancreatic ductal adenocarcinoma represent the "cold tumors". Overall, cold tumors show a low activation of the immune system and tend to not respond to immunotherapy. For this class of tumors, which represent up to 80% of all cancers, it is necessary to identify predictive biomarkers and/or new targets of non-canonical immunotherapy.
iii) The clinical use of conventional immunotherapeutic agents (i.e. immune checkpoint, such as PD-1/PD-L1 and CTLA-4, inhibitors) has paved the way for a new era of anti-cancer strategies being developed. Indeed, many other soluble checkpoints, such as soluble B7-H3 and CD80, are currently under investigation. Of the wide range of receptors expressed by immune cells, many other molecules profoundly influence the activation status of the immune system: for instance, cytokines, vesicles and tumor-derived soluble factors, which are promising candidates as potential biomarkers or new targets for more effective immunotherapies.

Even if immunotherapy has significantly improved the quality of life of patients with malignancies in the last decade, many mechanisms of primary and acquired resistance are still unknown and urgently need to be identified. This Research Topic aims to uncover new insights in immunotherapy strategies in the clinic management of gastrointestinal cancer patients. We encourage authors to submit manuscripts focused on by not limited to:
- Soluble cytokines and chemokines with potential beneficial outcomes in GI cancers
- Soluble immune checkpoints as clinical biomarkers and therapeutic targets
- Circulating cells of relevance in GI cancers
- Circulating DNA and its role as a therapeutic target or biomarker

Studies including basic research, translational research, and clinical research are welcomed. We accept “original research”, “systematic reviews”, “meta-analysis”, “reviews”, “clinical trial”, and “brief research report”. Other types of manuscript will be evaluated by the editors before further consideration.

Important Note: Manuscripts consisting solely of bioinformatics, computational analysis, or predictions of public databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) will not be accepted in any of the sections of Frontiers in Oncology.

Research Topic Research topic image

Keywords: Circulating biomarkers, Soluble factors, cytokines, chemokines, immune checkpoints, Circulating cells, Circulating DNA, Immunotherapy, Gastrointestinal cancer

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Frequently asked questions

  • Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

    Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

  • The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

    Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

  • As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

    A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

  • Each Research Topic must be approved by the specialty chief editor, and it falls under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

    In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

  • Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

    As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

    Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

  • Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

    Check available article types here 

  • Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

    Suggest your topic here 

  • A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

    The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

  • As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

    You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

  • As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

  • If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

  • Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

  • Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

  • As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

    Find out more about our Research Topics

  • Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

    Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

  • In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.

Participating Journals

Impact

  • 15kTopic views
  • 10kArticle views
  • 4,739Article downloads
View impact